Supplementary Table 2. Prespecified outcomes*,† for recombinant zoster vaccine (RZV) in reports submitted to the Vaccine Adverse Events Reporting System (VAERS) — United States, October 2017–June 2018
Public Domain
-
February 28, 2019
File Language:
English
Details
-
Journal Article:Morbidity and Mortality Weekly Report (MMWR)
-
Description:Supplements: Post-licensure safety Surveillance of recombinant zoster vaccine (Shingrix) —Vaccine Adverse Event Reporting System (VAERS), United States, October 2017–June 2018
-
Subjects:
-
Source:MMWR. Morbidity and Mortality Weekly Report ; v. 68, no. 4
-
Series:
-
ISSN:0149-2195 (print) ; 1545-861X (digital)
-
Document Type:
-
Genre:
-
Place as Subject:
-
Pages in Document:1 pdf page
-
Volume:68
-
Issue:4
-
Collection(s):
-
Main Document Checksum:urn:sha-512:e62ee2043cafd1649ba84b312997442c4a9de80a0d99cf8c23175d5b848ad61e5354fd217b6b84d3357f13e8f210cc1d87d7c170081bfd3f88d17beb57816861
-
Download URL:
-
File Type:
Related Documents
File Language:
English
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
Morbidity and Mortality Weekly Report (MMWR)